ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DBD vs VYX // NET PROFIT MARGIN

Diebold Nixdorf Incorporated (NYSE) VS. NCR Voyix Corporation (NYSE) • 15-METRIC TALLY: DBD 9 — VYX 2
▲ NET PROFIT MARGIN LEADER: DBD
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DBD VS. VYX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DBD VYX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 25.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 11.50% 1.10% +10.40 DBD /roic <GO>
EV/EBITDA & P/E Valuation 10.6x 77.1x -66.50 DBD /valuation <GO>
Free Cash Flow Yield 15.14% -18.50% +33.64 DBD /fcf-yield <GO>
Operating Margin 6.40% 1.00% +5.40 DBD /operating-margins <GO>
Net Profit Margin ACTIVE 2.50% 2.30% +0.20 DBD /net-margins <GO>
Revenue Growth (YoY) 1.50% -4.60% +6.10 DBD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.79 1.16 +0.63 DBD /balance-sheet <GO>
Piotroski F-Score Quality 8/9 2/9 +6.00 DBD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 27.7 60.9 -33.18 VYX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 19.5x 17.0x +2.50 VYX /forward-pe <GO>
Enterprise Scale & Market Cap $1.99B $1.13B $851.4M DBD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DBD REV VYX REV DBD GROSS % VYX GROSS % DBD FCF VYX FCF
FY 2025 $3.81B $2.69B 25.3% — $300.7M -$210.0M
FY 2024 $3.75B $2.82B 24.5% — $149.2M -$162.0M
FY 2023 — $3.17B — — — $694.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DBD // BETA —
VYX // BETA —